Outpace Bio

Marc Lajoie, Ph.D., Co-Founder and CEO

Oct. 12 | 10:30am | Rentschler ATMP Ballroom 

Seattle, WA


Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy, recruit a productive immune response in the tumor microenvironment, and achieve the potency, specificity, and safety necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes.


By using this website you agree to accept our Privacy Policy and Terms & Conditions